Agodoa LY - Search Results

1

Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group.

Cheung AK, Agodoa LY, Daugirdas JT, Depner TA, Gotch FA, Greene T, Levin NW, Leypoldt JK. Cheung AK, et al. Among authors: agodoa ly. J Am Soc Nephrol. 1999 Jan;10(1):117-27. doi: 10.1681/ASN.V101117. J Am Soc Nephrol. 1999. PMID: 9890317 Clinical Trial.

2

Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival.

Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, Pereira BJ, Agodoa LY, Port FK. Leypoldt JK, et al. Among authors: agodoa ly. Am J Kidney Dis. 1999 Feb;33(2):349-55. doi: 10.1016/s0272-6386(99)70311-2. Am J Kidney Dis. 1999. PMID: 10023649

3

Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study.

Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G. Cheung AK, et al. J Am Soc Nephrol. 2003 Dec;14(12):3251-63. doi: 10.1097/01.asn.0000096373.13406.94. J Am Soc Nephrol. 2003. PMID: 14638924 Clinical Trial.

4

Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.

Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G. Cheung AK, et al. J Am Soc Nephrol. 2006 Feb;17(2):546-55. doi: 10.1681/ASN.2005020132. Epub 2005 Dec 28. J Am Soc Nephrol. 2006. PMID: 16382021

5

Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study.

Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T, Keshaviah PR. Leypoldt JK, et al. Among authors: agodoa ly. Kidney Int. 1997 Jun;51(6):2013-7. doi: 10.1038/ki.1997.274. Kidney Int. 1997. PMID: 9186896 Free article.

6

Prescription of twice-weekly hemodialysis in the USA.

Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LY, Daugirdas JT. Hanson JA, et al. Among authors: agodoa ly. Am J Nephrol. 1999;19(6):625-33. doi: 10.1159/000013533. Am J Nephrol. 1999. PMID: 10592355 Clinical Trial.

7

Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study.

Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ. Port FK, et al. Among authors: agodoa ly. Am J Kidney Dis. 2001 Feb;37(2):276-86. doi: 10.1053/ajkd.2001.21290. Am J Kidney Dis. 2001. PMID: 11157367

8

Effect of the dialysis membrane on mortality of chronic hemodialysis patients.

Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agodoa L. Hakim RM, et al. Kidney Int. 1996 Aug;50(2):566-70. doi: 10.1038/ki.1996.350. Kidney Int. 1996. PMID: 8840287 Free article.

9

Association of serum albumin and atherosclerosis in chronic hemodialysis patients.

Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, Ornt D, Cheung AK; HEMO Study Group. Beddhu S, et al. Am J Kidney Dis. 2002 Oct;40(4):721-7. doi: 10.1053/ajkd.2002.35679. Am J Kidney Dis. 2002. PMID: 12324906

10

Body size, dose of hemodialysis, and mortality.

Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK. Wolfe RA, et al. Among authors: agodoa ly. Am J Kidney Dis. 2000 Jan;35(1):80-8. doi: 10.1016/S0272-6386(00)70305-2. Am J Kidney Dis. 2000. PMID: 10620548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page